Disclaimer: Product Under Development. Subject to FDA Clearance
Team Cern Expanding – Key Roles
Cern Corporation – Developing a much-needed, non-drug therapy, for mitigation of yeast & bacterial vaginosis (without the need for drugs), is excited to welcome new key members to the team.
Dr. Neal Lonky, OBGYN, MPH – Dr. Lonky is a recognized leader in women’s healthcare occupying significant roles at both Kaiser Permanente as well as The University of California Irvine as a practicing physician, research lead and key investigator. Dr. Lonky has provided significant support to SCMPMG to improve patient care, safety, and affordability and is an acknowledged expert in women’s health policy and management. Additionally, Dr. Lonky is on the Editorial Board of American Society of Colposcopy Journal of Lower Genital Tract Disease and Contributing Editor for OBG Management. Editorial Board of American Society of Colposcopy Journal of Lower Genital Tract Disease and Contributing Editor for OBG Management. Dr. Lonky’s association with Kaiser includes, Practicing Physician, Elected Board of Directors, Chairman of the Quality Committee of the Board of Directors, Oversight of operations and policy for the Southern California Permanente Medical Group in concert with Kaiser Foundation. Co-Chairman of the Elected Board of Directors, Chairman of the Quality Committee of the Board of Directors. Association with The University of California Irvine includes roles as Clinical Professor as well as Faculty Clinical Professor at the Dept. of Obstetrics and Gynecology. Dr. Lonky is also CEO, Founder (and inventor) at Histologics LLC, who’s focus is minimally Invasive tissue sampling and wound hygiene/debridement devices.
Joanne Rupprecht, Esq., RAC, ACRP-CP, CCEP, ACUE – Attorney and Regulatory/Quality Consultant for Medical Devices, Biologics and Pharmaceuticals. Joanne’s principal focus is regulatory strategy and quality management for medical device, biologic (including stem and CAR-T Cell), and pharmaceuticals with significant experience in human clinical trials and regulatory submissions to FDA. Joanne is also an adjunct professor at The University of Colorado, Anschutz Medical Campus where she teaches graduate students in the Biomedical Science and Biotechnology (BSBT) program, Federal Agency Law and healthcare product development.
Gary Kaiser, MBA – Gary has significant experience in bringing novel medical devices to market. Most recently, Gary was a significant force helping to develop, manufacture, and market medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Gary’s background in medical device as well as “Femtech”, provides significant background and depth to assist Cern Corporation.
“The ability to align this type of significant talent to Cern’s mission, the mitigation of yeast & bacterial vaginosis – without the need for systemic, antifungal/antibiotics, is affirmation as what we are doing for women’s health clearly resonates with subject matter experts in various capacities”. Gregg A. Klang, Cern Corp. CEO and Founder
The Cern Device…For those for whom drug based therapies are neither effective, appropriate, or desired!
30 April 23
Thank you. Let’s stay in touch!
On behalf of “Team Cern”, thank you for all the tremendous support as we bring to market what so many believe...
20 April 23
Interview Outtake 7: Making the world better
20 April 23